The Glutamate Antagonist Riluzole and Its Effects upon Basal and Stress-Induced Activity of the Human Hypothalamus-Pituitary- Adrenocortical System in Elderly Subjects

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neuropsychobiology

• Publication date

  2001-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000054873PMID 11174052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypothalamic mechanisms mediating glutamate effects on the hypothalamo-pituitary-adrenocortical axis

  2005cited by this paper
• Simultaneous Blockade of Two Glutamate Receptor Subtypes (NMDA and AMPA) Results in Stressor-Specific Inhibition of Prolactin and Corticotropin Release

  1999cited by this paper
• With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens.

  1997cited by this paper
• Glutamate and N‐Methyl‐D‐Aspartate Stimulate Rat Hypothalamic Corticotropin‐Releasing Factor Secretion in vitro

  1997cited by this paper
• Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamine release.

  1995cited by this paper
• Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression.

  1995cited by this paper
• A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.

  1994cited by this paper
• Stress, Feedback and Facilitation in the Hypothalamo‐Pituitary‐Adrenal Axis

  1992cited by this paper
• Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid.

  1991cited by this paper
• N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat.

  1991cited by this paper
• Hormonal responses to exhausting physical exercise: the role of predictability and controllability of the situation.

  1990cited by this paper
• Unexpected inhibitory action of N-methyl-D,L-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic-adrenal axis.

  1990cited by this paper
• Paraventricular stimulation with glutamate elicits bradycardia and pituitary responses.

  1989cited by this paper
• Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion.

  1989cited by this paper
• Stimulation of pituitary hormone secretion by neurotransmitter amino acids in humans.

  1989cited by this paper
• Effects of weight loss on the dexamethasone suppression test.

  1983cited by this paper
• Effect of intraventricular glutamate on ACTH release.

  1975cited by this paper

• Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection.

  2016cites this paper
• Effect of blockade of mGluR5 on stress hormone release and its gene expression in the adrenal gland.

  2014cites this paper
• The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes.

  2011cites this paper
• Advances in the treatment of anxiety: Targeting glutamate

  2011cites this paper
• Riluzole in psychiatry: a systematic review of the literature

  2008cites this paper
• Riluzole and D-amphetamine interactions in humans.

  2008cites this paper
• Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome.

  2008cites this paper
• Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis.

  2007cites this paper
• Control of ACTH secretion by excitatory amino acids

  2005cites this paper
• Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.

  2005cites this paper
• Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims

  2005cites this paper
• [From the biology of trauma to secondary preventive pharmalogical measures for post-traumatic stress disorders].

  2005cites this paper
• De la biologie du trauma aux pistes pharmacologiques de prévention secondaire de l’état de stress post-traumatique

  2005cites this paper
• Modulation of Neuroendocrine Response and Non-Verbal Behavior during Psychosocial Stress in Healthy Volunteers by the Glutamate Release-Inhibiting Drug Lamotrigine

  2004cites this paper
• Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy.

  2004cites this paper
• [Glutamatergic neurotransmission as molecular target in anxiety].

  2003cites this paper
• Transmissão pelo glutamato como Transmissão pelo glutamato como alvo molecular na ansiedade alvo molecular na ansiedade Glutamatergic neurotransmission as Glutamatergic neurotransmission as molecular target in anxiety molecular target in anxiety

  2003cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• Magnesium and Affective Disorders

  2002cites this paper
• Molecular targets in the treatment of anxiety.

  2002cites this paper
• Oral Mg2+ Supplementation Reverses Age-Related Neuroendocrine and Sleep EEG Changes in Humans

  2002cites this paper
• Anti-Aging Medicine LiteratureWatch

  2001cites this paper
• Current Awareness in human psychopharmacology

  2001cites this paper